Health and Wellness begins at the cellular level and it is estimated that over 5-million patients have been treated with some form of cell therapy since the 1930s. Cell therapy is widely used in many countries within the field of regenerative medicine, as a first resort not the last.
Cell therapy potentially restores function to injured, diseased, and debilitated tissues and organs. This is accomplished by simple injections of stem cells - which "home" to your injured tissues and organs to rejuvenate your own cells. This therapy tends to work best when treating chronic degenerative diseases, non-healing wounds, immune incompetence, virus related tumor therapy, premature aging, and endocrine (glandular) dysfunction.
Cell therapy is a better treatment for hepatitis and a powerful tool for cirrhosis of the liver with no serious risk or adverse reactions. Some advanced complications such as acute inflammatory stage or decompensated cirrhosis stage with portal hypertension, e.g. edema, ascities, bleeding esophageal varices can lessen the results, but treating liver inflammation prior to cell therapy can increases the effectiveness of treatment. For transplantation of each specific cell (liver, spleen, adrenal cortex, placenta and mesenchyme) there are genes coded to trigger key reactions for cell repair and reconstruction in the liver. In Russia and Germany several clinical studies in children ages six to twelve showed eradication of chronic aggressive hepatitis within twelve months after stem cell treatment. Since 1990 cellular transplantation has proven to be a preferred treatment over the serious side effects that can occur with administering peginterferon a-2 with ribavirin. Over 1000 medical papers have been written since the 1930's on stem cell transplantation (sampling), the past four decades has shown, Progenitor Cell treatment can stop the relentless progress of the complications of hepatitis. After the diagnosis of hepatitis disease is established, stem cell treatment given early can increase the success rate of the treatment. Statistics prove the effectiveness with a success rate of approximately 66% to 100% eradication especially among young patients. Compensated cirrhosis of the liver and chronic hepatitis have been successfully treated by cellular therapy for over forty years; with both diseases especially prominent throughout in Germany during the 1940's through the 1960's as a result of a severe epidemic of viral hepatitis near the end of World War 2.
Since there is still no effective, treatment for a damaged liver, cell therapy continues to be treatment of choice for serious liver diseases! Essentially, all liver patients can be helped by cell therapy, unless it is in the acute inflammatory stage or decompensated cirrhosis stage with portal hypertension, e.g. edema, ascities, bleeding esophageal varices, etc.
Before a patient can be treated with cell therapy, all inflammation within the liver must be first eliminate before commencing cell therapy; otherwise, any favorable outcome from cell therapy cannot be predicted.
Millions of patients suffer from the hepatitis C virus worldwide. Ultimately, 75 to 80% of patients with acute hepatitis C develop chronic hepatitis C - with 80% of those eventually acquiring cirrhosis of the liver. Moreover, chronic hepatitis is the cause for about one-half of all cases of primary liver cancer within the developed world.
The best conventional therapy today, with the exception of cell therapy, is the combining of peginterferon a-2 with ribavirin. However, this is not suitable for young children or older adults, with contraindications occurring frequently in several different medical conditions. There are also many side effects from the drugs, with some more serious than others, including possible worsening of the disease.
Our physicians have used cell therapy to treat hepatitis C since the early 1990s. In late 1995, at the world health symposium in Moscow, a study was presented by Russia research physicians regarding cellular treatment of eight children from 9 - 12 years of age diagnosed with chronic persistent hepatitis. The study found that the right lobe of the liver decreased in size by 66%, left lobe by 50%, and spleen by 66% - all within 7 days after cell implantation of liver, spleen, adrenal cortex, placenta and mesenchyme. Moreover, total bilirubin dropped 33%, AST dropped from 41 to 31 u, and ALT from 40 to 34 u.
A second study of eight children 6 - 12 years of age diagnosed with chronic aggressive hepatitis was subsequently undertaken, with the right lobe of liver decreasing 45% on average, left lobe 30%, and spleen 60%. Total bilirubin, etc were lowered similarly as well.
Since the unification of East and West Germany, our chief physician, Ulrich Friedrichson, M.D., PhD has treated treatment of tens of hundreds of former eastern bloc patients suffering from various liver diseases, and in many cases, Dr. Friedrichson has seen a complete eradication of the liver disease in little as twelve months after commencement of treatment.
Not at all... for over 70-years cell therapy has been used safely and effectively in Europe, Russia, Republic of China, New Zealand, Middle East, Pacific Rim, Central and South America, Mexico and more recently the United States, under select clinical trials.
Cell Therapy is a natural product, not a drug and has very little or no adverse side effects. All cellular products are lawfully manufactured, and regulated under strict European Union guidelines.
Cell transplants are antigen free, thus no post immuno-suppression drugs are needed when treating hepatitis (A,B,C).
It requires a simple implantation with each cell transplant injected in muscle of the buttocks. Simple as a vitamin B shot. After your initial treatment you go home with a two-month supply of frozen stem cells in vials, which can be administered by a family member or health professional giving you the best long-term results.
After learning which stem cells would be best for you - patients are then able to make a decision of autologous stem cells (patient's own cells) or adult progenitor xenocells (animal cells), along with organ extracts & growth factors. These "cellular products" are delivered to physicians who have been approved to prescribe and administer cellular therapies to qualified hepatitis (A,B,C) patients.
Clinical application and research has found xenocells to be the most regenerating and long lasting. They are young and strong fetal cells and (unlike many adult patient cells).
ProGenaCell has taken the time, research and guesswork out of locating physicians who have the track record, education, training and experience administering advanced cellular therapy. In addition, to finding the most effective stem cells for patients suffering from hepatitis (A,B,C), ProGenaCell can help you every step of the way, including being your medical liaison in a foreign country. Your trip to the clinic will be worry free. ProGenaCell is about honesty, integrity and dedication, along with being a friend and advocate for you the patient.
After you have educated yourself by watching our video at ProGenaCell Video Channel and read the testimonials, we invite you to look over our periodical list, which is the research backing up all the information and your questions. When you are ready... fill out the on-line questionnaire, which will be sent to one of our referring Doctors, and a representative will give you a call to answer all of your specific questions in detail. We look forward to hearing from you soon!
Fill out an Information Request Form Today! How can we help?